Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-binding cassette sub-family C member 10 (ABCC10), also known as Multidrug resistance-associated protein 7 (MRP7), is a transmembrane protein that functions as an ATP-dependent efflux pump [1, 5]. It belongs to the C subfamily of the ABC transporter superfamily and is characterized by its ability to transport a broad spectrum of substrates, including amphipathic anions and various xenobiotics [1, 2]. In the context of oncology, ABCC10 is a significant mediator of multidrug resistance (MDR), as it actively extrudes several classes of chemotherapeutic agents such as taxanes (paclitaxel and docetaxel), vinca alkaloids, and epipodophyllotoxins from cancer cells [2, 3]. This efflux activity lowers the intracellular concentration of these drugs, thereby diminishing their cytotoxic effects and leading to treatment failure [3, 4]. Beyond its role in cancer, ABCC10 is expressed in normal tissues like the liver, lung, and gastrointestinal tract, where it likely contributes to the protection of cells from toxic substances [1, 5]. Research into ABCC10 inhibitors aims to reverse drug resistance and enhance the efficacy of existing chemotherapies, although maintaining selectivity to avoid systemic toxicity remains a primary challenge [4]. Sources: [1] UniProt (Q5T3U5); [2] Hopper-Borge et al. (2004) Cancer Res; [3] Kruh et al. (2007) Cancer Metastasis Rev; [4] Kathawala et al. (2015) Mol Cancer Ther; [5] NCBI Gene (ID: 124411).
ABCC10 functions as an ATP-dependent efflux pump that transports chemotherapeutic agents out of the cell, thereby reducing their intracellular accumulation and conferring resistance to treatment [1, 3].
13 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-binding cassette sub-family C member 10 (ABCC10) (ABCC10).